Nitrocellulose Membrane Selection for Lateral Flow Assays: How Pore Size, Flow Rate, and Protein Binding Determine IVD Performance

The Nitrocellulose Membrane: The Engine of Every Lateral Flow Assay

Every lateral flow immunoassay (LFIA) depends on one component more than any other to deliver its result: the nitrocellulose membrane. It is the substrate on which capture reagents are immobilized, the channel through which the sample migrates, and the surface where the visible signal appears. Get the membrane selection wrong and no amount of optimization in conjugate preparation, sample pad treatment, or reader algorithm development will compensate. Get it right, and the rest of the assay development process becomes markedly more tractable.

This guide addresses the technical decisions involved in selecting nitrocellulose membranes for lateral flow immunoassays used in in vitro diagnostic (IVD) products. It covers the physical and chemical properties that determine membrane performance, the major suppliers and their product portfolios, practical guidance for reagent deposition, and the regulatory implications of membrane as a critical raw material. The intended audience is IVD development scientists, manufacturing engineers, regulatory affairs professionals, and anyone responsible for making or defending membrane selection decisions for products that will be submitted to FDA, assessed under EU IVDR, or marketed globally.

Why Nitrocellulose Dominates Lateral Flow

Nitrocellulose has been the dominant membrane material for lateral flow immunoassays since the technology's commercial emergence in the late 1980s, and for good reason. Four properties make it uniquely suited to this application.

First, nitrocellulose has an exceptionally high protein binding capacity, driven by both hydrophobic and electrostatic interactions. Proteins adsorb to the nitrocellulose surface through hydrophobic interactions with the polymer backbone, while electrostatic forces between charged amino acid residues and the membrane surface provide additional binding energy. This dual mechanism yields protein binding capacities that far exceed those of most alternative membrane materials, enabling the immobilization of capture antibodies at concentrations sufficient to generate strong, visible signals at the test and control lines.

Second, nitrocellulose can be cast as a porous membrane with pore sizes in the range of 3 to 20 micrometers -- large enough to permit capillary-driven lateral flow of aqueous samples without external pumping, yet small enough to provide the enormous internal surface area needed for protein immobilization. The pore structure is tortuous and interconnected, creating a high-surface-area matrix that maximizes the available binding sites within a membrane thickness of just 100 to 180 micrometers of active nitrocellulose.

Third, nitrocellulose membranes are wettable with aqueous solutions. The material absorbs and transports water-based samples through capillary action without requiring surface modification that would diminish protein adsorption. While manufacturers do apply proprietary surfactant treatments to control wetting behavior and reduce background, the underlying nitrocellulose polymer is intrinsically compatible with the aqueous buffers used in immunoassay formulations.

Fourth, decades of industrial manufacturing experience have produced a mature, capable supply chain. The major membrane suppliers -- Sartorius, Merck Millipore, and Cytiva -- each operate dedicated production lines with process controls refined over decades. This manufacturing maturity translates into product consistency, documented specifications, regulatory familiarity, and the kind of supply security that IVD manufacturers need for products with shelf lives measured in years.

Alternatives exist -- cellulose acetate, polyvinylidene fluoride (PVDF), charge-modified nylon, and polyethersulfone (PES) membranes have all been investigated for lateral flow applications. Each offers some advantage in specific scenarios: PVDF provides higher chemical resistance, nylon offers different charge characteristics, and PES delivers low protein binding for certain non-immunoassay formats. But none matches nitrocellulose's combination of protein binding capacity, capillary flow behavior, visual signal contrast, and supply chain maturity. For the vast majority of commercial lateral flow IVDs, nitrocellulose remains the only practical choice.

The Critical Membrane Parameters

Understanding how nitrocellulose membranes are specified -- and what those specifications mean for assay performance -- is the foundation of informed membrane selection. The following parameters are the ones that matter most.

Pore Size

Pore size, typically expressed as the average pore diameter in micrometers, is the single most commonly cited membrane specification. For lateral flow membranes, pore sizes range from approximately 3 micrometers at the small end to 20 micrometers at the large end. Pore size correlates inversely with internal surface area: membranes with smaller pores present more total surface area per unit volume, providing more sites for protein immobilization and, consequently, higher potential capture capacity.

However, pore size is not the primary specification most experienced assay developers use to select membranes. That distinction belongs to capillary flow rate, which captures the combined effect of pore size, pore geometry, membrane thickness, and surface chemistry on actual fluid transport behavior. Two membranes with nominally identical pore sizes from different manufacturers can exhibit meaningfully different flow characteristics due to differences in pore structure, surfactant treatment, and nitrocellulose casting process.

Capillary Flow Rate

Capillary flow rate is the specification that most directly determines how a membrane will behave in an assay. It is measured as the time in seconds required for a defined volume of water or aqueous buffer to wick a specified distance along the membrane strip, most commonly expressed as seconds per 40 millimeters (also written as seconds per 4 cm).

This specification ranges from approximately 65 seconds per 40 millimeters for fast-flowing membranes to approximately 240 seconds per 40 millimeters for the slowest membranes used in high-sensitivity applications. Each supplier designates their membrane grades by flow rate, making this the most intuitive parameter for initial selection:

• Fast membranes (approximately 65-90 seconds per 40 mm) produce short assay run times, which is desirable for point-of-care and over-the-counter products where rapid results are a competitive requirement. The tradeoff is reduced interaction time between the analyte and the capture reagents immobilized at the test line. For high-abundance targets where sensitivity is not the limiting concern, fast membranes are appropriate. Millipore HiFlow Plus HF75, with a nominal flow rate of 75 seconds per 4 cm, is a widely used fast membrane.

• Medium-flow membranes (approximately 90-140 seconds per 40 mm) represent the middle ground and are the starting point for most new assay development projects. Sartorius Unisart CN 140, with a specification range of 95-155 seconds per 40 mm in the backed format, is a benchmark membrane in this category.

• Slow membranes (approximately 140-240 seconds per 40 mm) maximize the residence time of the sample at the test and control lines, increasing the probability of analyte-capture reagent interaction. These membranes are selected when the target analyte is present at low concentrations and sensitivity is the primary performance requirement. Millipore HF180 (180 seconds per 4 cm nominal) is a common choice for high-sensitivity applications. The cost of slower flow is longer assay time and, often, increased background signal.

The flow rate-sensitivity tradeoff is the central tension in membrane selection. Faster flow improves the user experience and reduces manufacturing cycle time but sacrifices the interaction time that drives capture efficiency. Slower flow increases capture efficiency but extends assay time and can elevate nonspecific binding, producing higher background that degrades the signal-to-noise ratio. The optimal flow rate is assay-specific and must be determined empirically during development.

Porosity and Bed Volume

Porosity -- the percentage of the membrane volume that is open pore space rather than solid polymer -- determines the membrane's liquid-holding capacity, also called bed volume. Typical nitrocellulose membranes for lateral flow have porosities in the range of 70-80%, meaning that the majority of the membrane volume is available for liquid transport.

Bed volume is important because it determines how much sample the membrane can accommodate and how much of that sample is available to interact with the capture reagents. A membrane with higher bed volume holds more sample, which can improve sensitivity for dilute analytes. Bed volume also affects the geometry of the test line: a membrane with higher bed volume distributes the test line reagent through a greater depth of the membrane, potentially increasing the effective capture zone.

Thickness

Membrane thickness affects bed volume, test line appearance, tensile strength, and manufacturability. For backed membranes, the total thickness (nitrocellulose layer plus polyester backing) typically ranges from 120 to 280 micrometers. The nitrocellulose layer alone is generally 100 to 180 micrometers.

Thicker membranes hold more liquid and can produce wider, more visually prominent test lines. Thinner membranes are more flexible (which matters for some cassette designs) and use less nitrocellulose per unit area, which can marginally reduce raw material cost. Thickness also influences signal visibility in reflectance-based readers: the optical properties of the membrane change with thickness, and reader algorithms may need to be calibrated for a specific membrane thickness range.

For commercial reel-to-reel manufacturing, consistent thickness across the membrane roll is essential for uniform dispensing and lamination. Suppliers specify thickness tolerance, and IVD manufacturers should verify incoming material thickness as part of their acceptance testing program.

Surface Chemistry and Surfactant Treatment

Nitrocellulose membranes are not simply raw polymer. All commercial lateral flow nitrocellulose membranes receive proprietary surfactant treatments during manufacturing. These treatments serve several purposes: they ensure consistent wettability across the membrane surface, they reduce nonspecific protein binding in areas outside the test and control lines, and they influence the morphology of reagent lines during striping.

The surfactant formulation is a closely guarded differentiator among membrane suppliers. Two membranes with identical nominal pore size and flow rate but from different manufacturers may perform differently in the same assay because of differences in surfactant chemistry. This is why switching membrane suppliers is never a simple drop-in replacement and always requires re-optimization and re-validation.

Some membranes are available in different surface treatment grades within the same pore size/flow rate designation, allowing developers to select variants optimized for specific assay chemistries. Cytiva's Immunopore and Prima lines, for example, offer surface modifications designed for particular application requirements.

Backing Types and Their Practical Implications

Unbacked Membranes

Unbacked nitrocellulose membranes consist of the nitrocellulose polymer layer alone, without any supporting substrate. They are more fragile than backed membranes and require more careful handling during manufacturing. Unbacked membranes also have two distinct surfaces -- the air side (the surface exposed to air during casting) and the belt side (the surface that was in contact with the casting belt) -- which can exhibit different protein binding and flow characteristics. This surface asymmetry adds a variable that must be controlled during manufacturing.

Unbacked membranes are used in specific applications where the backing material would interfere with the optical path in a reader system, where extreme thinness is required, or where the manufacturing process is designed for unbacked material handling. They are less common in high-volume commercial IVD production.

Backed Membranes

The overwhelming majority of commercial lateral flow IVDs use backed membranes, in which the nitrocellulose layer is laminated to a polyester (PET) film, typically approximately 100 micrometers thick. The backing provides several practical advantages:

• Mechanical stability: Backed membranes are robust enough for high-speed reel-to-reel processing, including automated dispensing, lamination to cards with sample pads and absorbent pads, and cutting into individual strips.
• Dimensional stability: The polyester backing prevents the membrane from stretching, shrinking, or distorting during processing, maintaining consistent strip dimensions.
• Handling: Backed membranes are easier to handle manually and automatically, reducing waste from tears and folds.

The backing comes in two variants: clear polyester and white polyester. Clear backing allows transmitted light to pass through the membrane, which can be advantageous for some optical reader configurations. White backing provides a reflective surface behind the nitrocellulose, which enhances the visual contrast of colored test lines -- important for visually read tests and for reflectance-based reader systems. For most commercial LFIA products, white-backed membranes are the standard choice.

Major Suppliers and Their Membrane Portfolios

The nitrocellulose membrane market for lateral flow assays is served by a small number of highly specialized suppliers. Understanding each supplier's product range, naming conventions, and specification system is essential for efficient membrane selection.

Sartorius (Unisart CN Series)

Sartorius manufactures the Unisart CN membrane line, which uses a numerical naming system where the number directly corresponds to the nominal capillary flow time in seconds per 40 millimeters. Key grades include:

• Unisart CN 95 (backed): Capillary flow rate specification 65-115 seconds per 40 mm. A fast-flow membrane suitable for assays where rapid results are prioritized.
• Unisart CN 110 (backed): Intermediate flow rate, offering a balance between speed and sensitivity.
• Unisart CN 140 (backed): Capillary flow rate specification 95-155 seconds per 40 mm. One of the most widely used grades for general-purpose LFIA development.
• Unisart CN 150 (backed): A moderate-slow membrane for assays requiring enhanced sensitivity.
• Unisart CN 180 (backed): Capillary flow rate specification 135-195 seconds per 40 mm. A slow-flow membrane selected for high-sensitivity applications where extended analyte-capture reagent interaction time is critical.

Note that Sartorius specifies each grade as a range (e.g., CN 140 backed: 95-155 seconds per 40 mm), not a single nominal value. This range represents the expected lot-to-lot variation and is important to account for during assay design and incoming material qualification.

Sartorius also offers the Unisart StructSure membrane, a next-generation product with engraved microfluidic channels and hydrophobic barriers patterned directly into the nitrocellulose, enabling multiplexed detection zones on a single strip without physical segmentation.

Merck / Millipore (HiFlow Plus Series)

Merck's Millipore brand offers the HiFlow Plus membrane line, named by the nominal flow time in seconds per 4 cm. The portfolio includes:

• HF65: Approximately 65 seconds per 4 cm. The fastest-flowing membrane in the HiFlow Plus range.
• HF75: Approximately 75 seconds per 4 cm. A widely specified fast membrane for rapid-result applications.
• HF90: Approximately 90 seconds per 4 cm. Fast-to-medium flow, suitable for moderate-abundance targets.
• HF120: Approximately 120 seconds per 4 cm. Medium flow, a versatile starting point for many assay types.
• HF135: Approximately 135 seconds per 4 cm. Medium-to-slow flow.
• HF180: Approximately 180 seconds per 4 cm. Slow flow for maximum sensitivity, one of the most frequently specified membranes for low-abundance analyte detection.

The HiFlow Plus membranes are available in both backed and unbacked formats and with different surface treatments. Millipore's technical documentation is extensive and widely referenced in the LFIA development literature.

Cytiva / Whatman

Cytiva (formerly GE Healthcare Life Sciences, incorporating the former Whatman brand) offers a broad portfolio of nitrocellulose membranes:

• FF80HP, FF120HP, FF170HP: The FF (Fast Flow) series with HP (High Protein) binding characteristics. Named by nominal flow time.
• Immunopore series: Surface-modified membranes designed for specific assay chemistries, offering optimized protein binding and reduced background.
• Prima: A membrane grade designed for general-purpose LFIA applications.
• Vivid LFNC: A line of lateral flow nitrocellulose membranes available in multiple pore size and flow rate grades.

Cytiva's portfolio is notable for the breadth of surface treatment options, which can be valuable when standard membranes from other suppliers produce unacceptable background or nonspecific binding in a particular assay chemistry.

Other Suppliers

• Axiva Biosciences (India): Manufactures CH, DF, and DE series membranes with specified pore sizes and wicking times. Axiva is a significant supplier to the Indian and Asian LFIA markets and offers competitive pricing for high-volume production.
• Advanced Microdevices (India): Supplies nitrocellulose membranes for lateral flow applications, serving primarily the South Asian market.
• Ahlstrom (Finland): Produces membrane and absorbent pad materials for the diagnostic industry, though their nitrocellulose membrane portfolio is more limited than the three major suppliers.

For IVD manufacturers pursuing regulatory approval in the US and EU, Sartorius, Merck Millipore, and Cytiva are the most commonly qualified suppliers, owing to their extensive regulatory support documentation, quality management system certifications, and track record with FDA and Notified Body audits.

Matching Membrane Selection to Sample Type

The biological matrix being tested influences optimal membrane selection more than many developers initially appreciate. Different sample types present different challenges for the membrane.

Urine

Urine is a relatively low-viscosity, low-protein matrix that flows easily through nitrocellulose. Fast to medium-flow membranes are generally appropriate for urine-based assays. The primary concern with urine is variability in pH, specific gravity, and ionic strength across the patient population, which can affect flow behavior and protein binding. Sample pad pre-treatment with buffering agents is commonly used to normalize these variables. Membranes with moderate surfactant treatment tend to perform well with urine samples because they manage the low-protein matrix without introducing excessive background.

Whole Blood, Serum, and Plasma

Blood-derived samples present the greatest challenge for membrane selection. Whole blood contains cells that must be separated before the sample reaches the test membrane. This separation is typically achieved using a plasma separation pad (PSP) or a glass fiber filter integrated upstream of the nitrocellulose membrane. The choice of membrane must account for the plasma that emerges from the separation step, which has higher viscosity and protein content than urine.

Medium to slow-flow membranes are often preferred for blood-based assays. The higher viscosity of plasma compared to urine means that flow rates will be slower than the water-based specifications suggest, and a membrane that is already slow-rated may produce unacceptably long assay times when used with plasma. Conversely, a fast membrane may not provide sufficient interaction time when the effective flow rate is further reduced by plasma viscosity.

Serum and plasma samples (without cells) offer more latitude in membrane selection but still require attention to the effects of protein content on flow and background.

Saliva and Oral Fluid

Saliva presents challenges of high viscosity, variable composition, and mucin content that can impede flow and increase nonspecific binding. Membranes with medium to slow flow rates are typically used, along with sample pad treatments that include mucolytic agents. The choice of surfactant treatment on the membrane is particularly important for saliva-based assays because mucins can interact with the membrane surface in ways that generate background signal.

Resolubilized Samples and Dried Specimens

Some assay formats involve drying a specimen (such as dried blood spots) and then resolubilizing it in a buffer before application to the test strip. The resolubilization buffer composition is controlled by the assay developer, which means the effective sample viscosity and composition can be optimized for the chosen membrane. In these cases, membrane selection follows the same principles as for the corresponding liquid sample type, with the additional degree of freedom that the buffer formulation can be tuned to match the membrane's flow characteristics.

Reagent Deposition: Striping Parameters That Interact With Membrane Properties

The process of immobilizing capture antibodies and control line reagents onto the nitrocellulose membrane -- commonly called striping or dispensing -- is intimately connected to membrane selection. The membrane's pore size, flow rate, and surface chemistry determine how the dispensed reagent solution behaves when it contacts the membrane surface.

Contact vs. Non-Contact Dispensing

Two primary dispensing methods are used in LFIA manufacturing:

• Contact dispensing: The dispensing tip makes physical contact with the membrane surface. A dispense rate of 0.5 to 1.0 microliters per centimeter is typical. Contact dispensing is simpler and less expensive to implement but risks membrane damage if the contact force is excessive, particularly with unbacked membranes.

• Non-contact dispensing (jet dispensing): Reagent is ejected from a nozzle without physical contact with the membrane. This method eliminates membrane damage risk and enables more precise line placement but requires more sophisticated and expensive equipment. Typical dispense volumes are comparable to contact dispensing.

How Membrane Properties Affect Line Formation

The width and uniformity of the reagent line depend on how the dispensed solution spreads laterally within the membrane after contact. Faster membranes (larger pores) allow the solution to spread more readily, producing wider lines at a given dispense rate. To compensate for this spread, lower dispense rates (for example, 0.8 microliters per centimeter rather than 1.0 microliters per centimeter) may be needed on fast membranes to maintain acceptable line width.

Conversely, slow membranes (smaller pores) constrain lateral spreading, producing narrower, more defined lines at a given dispense rate. This can be advantageous for achieving sharp, high-contrast test lines but may concentrate the capture reagent into a smaller zone, potentially reducing the effective capture area.

The protein concentration in the dispensing buffer (typically in the range of 0.5 to 2.0 mg/mL for capture antibodies) must be optimized in conjunction with the dispense rate and membrane flow rate to achieve the desired line intensity and assay sensitivity. Higher protein concentrations generally produce more intense lines but increase reagent cost and can lead to protein aggregation or denaturation during drying.

Drying Conditions

After dispensing, the reagent lines must be dried before the membrane is laminated and cut. Drying conditions -- temperature, humidity, and duration -- affect the final conformation and activity of the immobilized proteins. Elevated temperature drying (typically 35-45 degrees Celsius) accelerates processing and is standard in high-volume manufacturing, but excessive heat can denature sensitive antibodies. Room temperature drying preserves protein activity but extends cycle time and requires longer production lines.

The interaction between drying conditions and membrane properties is often overlooked. Membranes with higher porosity and bed volume retain more moisture after dispensing, requiring longer drying times or higher temperatures to achieve complete desiccation. Incomplete drying can lead to antibody denaturation, reduced capture efficiency, and poor lot-to-lot reproducibility.

Lot-to-Lot Qualification: The Critical Manufacturing Discipline

Nitrocellulose membranes are inherently variable. The casting process that creates the porous nitrocellulose structure is a complex chemical engineering operation, and despite sophisticated process controls, some variation in pore structure, flow rate, surface chemistry, and protein binding capacity occurs between production lots. This variation is normal and expected -- it is why suppliers specify their membranes as ranges rather than fixed values.

The implication for IVD manufacturers is clear: membrane qualification must be based on functional assay performance, not on supplier specification sheets alone. A rigorous lot-to-lot qualification program includes the following elements:

1. Evaluate membranes across the full specification range during development. During assay optimization, deliberately test membranes from multiple lots that span the supplier's specification range for flow rate and other parameters. This reveals whether the assay performance is robust to the expected lot-to-lot variation or whether tighter incoming acceptance criteria are needed.

2. Define acceptance criteria based on functional performance. Incoming material testing should include a functional assay -- not just physical measurements like flow rate and thickness -- that directly assesses whether the membrane produces acceptable test results. Common approaches include running a panel of characterized samples (positive at the clinical decision point, negative, and borderline) on each incoming membrane lot and comparing the results to established reference ranges.

3. Monitor trend data. Track flow rate, protein binding, and functional performance across incoming lots over time. Trends that suggest the supplier's process is drifting can be identified early, before out-of-specification material arrives.

4. Establish a change notification agreement with the supplier. Require the membrane supplier to notify you of any changes to their manufacturing process, raw materials, or quality specifications -- even changes that the supplier considers minor. What the supplier considers a minor surfactant adjustment may have significant effects on your assay performance.

5. Maintain safety stock. Because membrane lots are not perfectly interchangeable, maintaining a qualified safety stock of at least three to six months of production supply provides buffer against supply disruptions and gives the manufacturer time to qualify new lots without interrupting production.

The cost of inadequate lot-to-lot qualification is not merely a manufacturing inconvenience. For a regulated IVD product, a batch failure traced to an out-of-specification membrane lot triggers a deviation investigation, potential lot rejection, and -- if the issue affects distributed product -- possible recall. The investment in robust incoming material qualification pays for itself many times over in avoided quality events.

Storage, Handling, and Shelf Life

Environmental Sensitivity

Nitrocellulose membranes are sensitive to environmental conditions in ways that can silently degrade assay performance if not properly controlled:

• Humidity: Nitrocellulose is hygroscopic. Elevated humidity during storage can alter the membrane's flow characteristics and affect the performance of the surfactant coating. Membranes should be stored in controlled-humidity conditions, typically below 50% relative humidity, in sealed packaging with desiccant.

• Temperature: Extreme temperatures can affect the surfactant treatment and the physical properties of the membrane. Storage at ambient temperature (15-25 degrees Celsius) is standard. Temperature cycling should be avoided.

• Chemical vapors: Nitrocellulose is sensitive to organic solvents and their vapors. Storage areas must be free from solvent exposure, including vapors from nearby manufacturing processes.

• Light: Prolonged exposure to direct sunlight or UV light can degrade nitrocellulose over time. Membranes should be stored in opaque or UV-protective packaging.

• Flammability: Nitrocellulose is a flammable material. Storage facilities must comply with applicable fire safety regulations. This is not merely a safety requirement -- it also affects warehouse classification and insurance costs.

Shelf Life Implications

Among all the components in a lateral flow test strip -- sample pad, conjugate pad, nitrocellulose membrane, absorbent pad, and backing card -- the nitrocellulose membrane can have the shortest shelf life. While membrane suppliers typically claim shelf lives of 18 to 24 months or more under proper storage conditions, the practical shelf life in the hands of the IVD manufacturer depends on storage conditions, packaging integrity, and the specific requirements of the assay.

The critical implication is that the shelf life of the finished IVD product may be limited by the membrane component. If the membrane is the rate-limiting component, the claimed shelf life of the distributed product must account for the time elapsed between membrane manufacture and finished product manufacture, plus the intended distribution and use period. IVD manufacturers must establish shelf life claims for the finished product through real-time and accelerated stability studies per ISO 23640 (Evaluation of stability of in vitro diagnostic reagents), and the membrane component must be included in this stability evaluation.

Market Context and Supply Chain Considerations

The global lateral flow immunoassay membrane market was estimated at approximately US$ 104 million in 2025 and is projected to reach US$ 172 million by 2032, representing a compound annual growth rate of approximately 8.3%. This growth is driven by the continued expansion of point-of-care testing, the proliferation of at-home diagnostic tests, and the increasing adoption of lateral flow formats for emerging applications including veterinary diagnostics, food safety testing, and environmental monitoring.

Several market structure details are relevant for IVD manufacturers:

• Membrane thickness: Membranes with a maximum thickness of 250 micrometers account for approximately 89.3% of global sales. This reflects the dominance of thin, backed membranes in commercial LFIA manufacturing.

• End-use segmentation: Medical diagnostics and point-of-care testing accounts for approximately 79.82% of membrane consumption. The remaining share is divided among veterinary diagnostics, food and beverage testing, pharmaceutical research, environmental testing, and other applications.

• Supply concentration: The market is highly concentrated among three primary suppliers -- Sartorius, Merck Millipore, and Cytiva -- with additional regional suppliers serving specific geographies. This concentration creates supply chain risk that IVD manufacturers must manage through dual sourcing or robust safety stock strategies.

• COVID-19 legacy: The pandemic-driven surge in lateral flow test production temporarily strained membrane supply and led several manufacturers to expand capacity. Some of this expanded capacity remains in the market, improving supply availability compared to pre-pandemic levels, though the long-term sustainability of this excess capacity is uncertain.

For regulatory purposes, the concentrated supplier base means that Notified Bodies and FDA reviewers are familiar with the major membrane suppliers and their specifications. This familiarity can streamline regulatory review when the membrane is identified by supplier and grade in the device master file, with appropriate incoming material controls documented in the quality management system.

Next-Generation Membrane Technology

While conventional cast nitrocellulose membranes remain the standard, several next-generation technologies are expanding the capabilities of lateral flow formats.

Structured Membranes for Multiplexing

Sartorius's Unisart StructSure membrane represents a significant departure from conventional flat nitrocellulose. Instead of a uniform porous sheet, StructSure features engraved microfluidic channels with integrated hydrophobic barriers that direct sample flow along defined paths. This architecture enables multiple independent detection zones on a single membrane strip, supporting true multiplexed assays without the cross-reactivity and flow distribution challenges that plague conventional multi-line lateral flow formats.

Structured membranes trade the simplicity of conventional lateral flow for enhanced functionality. They require modified manufacturing processes for reagent deposition and assembly, but they enable assay designs that would be impractical or impossible with standard flat membranes.

Alternative Membrane Materials

While no alternative material has displaced nitrocellulose for mainstream lateral flow immunoassays, several are being developed for specific applications:

• Cellulose acetate membranes offer lower protein binding, which is useful for non-immunoassay detection formats where low background is more important than high capture capacity.
• PVDF membranes provide higher chemical resistance and are used in some specialty lateral flow applications, though their lower protein binding capacity and higher cost limit their adoption.
• Charge-modified nylon membranes offer tunable surface charge characteristics that can be optimized for specific protein capture requirements.
• Polyethersulfone (PES) membranes provide very low protein binding, making them suitable for applications where nonspecific adsorption must be minimized.

These alternatives remain niche. For any new LFIA IVD product where the detection format relies on antibody-antigen capture, nitrocellulose should be the default starting point unless a specific, well-characterized requirement drives the selection of an alternative material.

Regulatory Considerations: Membrane as a Critical Raw Material

Under both FDA's Quality System Regulation (21 CFR Part 820, transitioning to the Quality Management System Regulation) and the EU IVDR's quality management requirements (Article 10), nitrocellulose membrane qualifies as a critical raw material for any lateral flow IVD. The membrane directly affects the analytical performance of the finished device, and changes to the membrane (grade, supplier, or manufacturing process) constitute changes to the device that must be evaluated under the manufacturer's change control process.

Supplier Qualification Under ISO 13485

ISO 13485:2016, Clause 7.4 (Purchasing), requires that organizations establish criteria for the evaluation, selection, monitoring of performance, and re-evaluation of suppliers based on their ability to supply product that meets the organization's requirements. For nitrocellulose membrane suppliers, this means:

• Initial supplier evaluation: Assess the supplier's quality management system (ISO 9001 certification at minimum; ISO 13485 certification is preferable but not always available for material suppliers), manufacturing capability, process controls, specification consistency, and regulatory track record. Conduct an on-site audit for the primary membrane supplier.
• Supplier agreements: Establish a Quality Agreement that defines responsibilities for change notification, complaint handling, batch traceability, and corrective actions. The change notification provision is particularly critical -- the supplier must agree to notify the IVD manufacturer before implementing any change to the membrane manufacturing process, raw materials, or specifications.
• Ongoing monitoring: Track supplier performance through incoming inspection results, functional assay performance, and on-time delivery metrics. Conduct periodic re-audits.

Incoming Material Testing

The incoming material acceptance program for nitrocellulose membranes should include:

• Physical measurements: Capillary flow rate verification (using the supplier's specified method), thickness measurement, visual inspection for defects, and width verification.
• Functional testing: Performance of the membrane in a reference assay, using characterized samples that represent the clinical decision point of the finished device.
• Acceptance criteria: Defined limits for each measured parameter, derived from the development data set that established the correlation between membrane properties and device performance.

Change Notification and Regulatory Impact

When a membrane change is proposed -- whether initiated by the supplier (process change, raw material change) or by the IVD manufacturer (grade change, supplier change) -- the impact must be assessed under the change control process. Depending on the nature and magnitude of the change, regulatory implications may include:

• FDA: A change in membrane supplier or grade may require a new 510(k) submission if it could significantly affect the safety or effectiveness of the device. Even changes that do not require a new submission must be documented in the device master record and validated under the quality system.
• EU IVDR: Changes to critical raw materials must be reported to the Notified Body as part of the ongoing conformity assessment. The Notified Body will evaluate whether the change requires re-certification or additional performance evaluation data.

A practical approach is to qualify multiple membrane grades or suppliers during development, even if only one is used in the initial product release. This proactive qualification provides regulatory flexibility and supply chain resilience without the delays associated with post-market qualification of an alternative material.

A Practical Framework for Membrane Selection

Bringing together the parameters, supplier options, and application considerations discussed above, a structured approach to membrane selection looks like this:

1. Define assay requirements first: Before evaluating any membrane, establish the target analyte concentration range, required sensitivity and specificity, acceptable assay time, sample type, intended use setting (laboratory, point-of-care, or over-the-counter), and read method (visual, reflectance reader, fluorescence reader). These requirements determine the acceptable flow rate range.

2. Select two to three candidate membranes: Based on the flow rate range implied by the requirements, select candidate membranes from one or more suppliers. Include at least one grade faster and one grade slower than the initially estimated optimum to provide development data at the boundaries.

3. Optimize on the primary candidate: Conduct full assay optimization (conjugate concentration, sample volume, sample pad treatment, buffer formulation, striping parameters, drying conditions) using the primary membrane candidate. This optimization establishes the baseline performance.

4. Evaluate robustness across the specification range: Using the optimized assay conditions, test membranes from multiple lots that span the supplier's specification range for flow rate. This reveals whether the assay is robust to normal lot-to-lot variation.

5. Benchmark against the alternative candidates: Run the optimized assay on the alternative membrane grades. This provides data for potential secondary sourcing and reveals whether a different grade offers performance advantages that were not apparent in the initial screening.

6. Document the selection rationale: Record the membrane selection decision, the data supporting it, the acceptable specification range, and the incoming acceptance criteria. This documentation supports regulatory submissions and future change control decisions.

7. Establish ongoing lot qualification: Implement the incoming material testing program before the first production run, not after.

The membrane selection decision is one of the earliest and most consequential choices in lateral flow IVD development. It deserves the same rigor and documentation as any other critical design input -- because that is exactly what it is.

Key Takeaways

• Nitrocellulose remains the dominant membrane for lateral flow immunoassays due to its unmatched combination of protein binding capacity, capillary flow behavior, visual contrast, and supply chain maturity.
• Capillary flow rate (seconds per 40 mm) is the most functionally relevant membrane specification and is the primary selection parameter. Flow rate determines the balance between assay speed and sensitivity.
• The flow rate-sensitivity tradeoff is the central design tension. Faster membranes produce shorter run times but reduce analyte-capture reagent interaction time. Slower membranes increase sensitivity but extend assay time and can elevate background.
• Backed membranes with polyester support are the standard for commercial manufacturing, providing the mechanical stability required for reel-to-reel processing.
• Sartorius, Merck Millipore, and Cytiva are the primary suppliers for regulated IVD products, each offering graded portfolios spanning the full flow rate range.
• Reagent striping parameters (dispense rate, concentration, drying conditions) must be co-optimized with membrane properties, not developed independently.
• Lot-to-lot qualification must be based on functional assay performance, not supplier specifications alone. Evaluate membranes across the full specification range during development.
• Nitrocellulose membranes are environmentally sensitive and can have the shortest shelf life of all lateral flow components, potentially constraining finished product shelf life claims.
• Membrane is a critical raw material under ISO 13485 and FDA quality system requirements. Supplier qualification, incoming material testing, and change notification agreements are mandatory, not optional.
• The global lateral flow membrane market (approximately US$ 104 million in 2025, growing to US$ 172 million by 2032) is concentrated among three suppliers, creating supply chain risk that must be managed through dual sourcing or safety stock strategies.